Roman Blaszczyk

6PUBLICATIONS
55CO-AUTHORS
Molecular targetsComputational chemistryBiologically active moleculesPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 06, 2026
Structure-Guided Discovery of OAT-4828 as Potent, Selective, and Orally Bioavailable USP7 Inhibitor with <i>In Vivo</i> Antileukemic Activity.

|Jun 25, 2024
Comparative analysis of RNA 3D structure prediction methods: towards enhanced modeling of RNA-ligand interactions.

Chandran Nithin, Sebastian Kmiecik, Roman Błaszczyk

|Mar 20, 2023
Arginase 1/2 Inhibitor OATD-02: From Discovery to First-in-man Setup in Cancer Immunotherapy.

Bartlomiej Borek, Julita Nowicka, Anna Gzik

|Aug 26, 2022
OATD-02 Validates the Benefits of Pharmacological Inhibition of Arginase 1 and 2 in Cancer.

Marcin Mikołaj Grzybowski, Paulina Seweryna Stańczak, Paulina Pomper

|Dec 11, 2021
Potent but transient immunosuppression of T-cells is a general feature of CD71<sup>+</sup> erythroid cells.

Tomasz M Grzywa, Anna Sosnowska, Zuzanna Rydzynska

|Jul 07, 2019
Small extracellular vesicles containing arginase-1 suppress T-cell responses and promote tumor growth in ovarian carcinoma.

Malgorzata Czystowska-Kuzmicz, Anna Sosnowska, Dominika Nowis

Pageof 1

Frequent Collaborators

3 joint publications

Jakub Golab

2 joint publications

Dominika Nowis

2 joint publications

Jacek Chrzanowski

2 joint publications

Adam Golebiowski